Hide filtersShow filters × Close Bryan, Garnier & Co advises Irium investors in the secondary LBO transaction to Initiative & Finance Bryan, Garnier & Co announces the success of the combination of ModeLabs Group with Bigben Interactive Bryan, Garnier & Co advises Metrologic Group’s founding shareholders on the sale of their majority stake to the Carlyle Group Bryan, Garnier & Co advises on the buy-out of DCI by its Management team, LBO France and Capzanine Bryan, Garnier & Co advised Synthetech in its sale to W. R. Grace & Co Bryan, Garnier & Co advises on the recapitalisation and buy-out of Solving Efeso by its Management and Argos Soditic Bryan, Garnier & Co advises the strategic merger of Assya Capital and Global Equities Capital Markets Bryan, Garnier & Co advises Compass Group in the acquisition of Caterine Restauration Bryan, Garnier & Co leads the sale of Viveo to Temenos for a total consideration of $81 million Bryan, Garnier & Co advised a hyperbaric oxygen therapy company on its sale to Candescent Partners. Bryan, Garnier & Co advises Mérieux Alliance for the divestiture of ShanH (the majority shareholder of the Indian vaccine company Shantha Biotechnics) to Sanofi-aventis Bryan, Garnier & Co has successfully advised majority shareholder GRED in the public tender offer & squeeze out of Softway Medical
